PT  - JOURNAL ARTICLE
AU  - Ariana Patras
AU  - Reinaldo Figueroa
AU  - Amit P Singh
AU  - Ichchha Madan
TI  - Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period
AID  - 10.1136/bcr-2020-234335
DP  - 2020 May 01
TA  - BMJ Case Reports
PG  - e234335
VI  - 13
IP  - 5
4099  - http://casereports.bmj.com/content/13/5/e234335.short
4100  - http://casereports.bmj.com/content/13/5/e234335.full
SO  - BMJ Case Reports2020 May 01; 13
AB  - We present a case of a pregnant woman with chronic immune thrombocytopenic purpura and chronic hypertension who developed pre-eclampsia with severe features warranting delivery. Her overall clinical picture and liver enzymes improved in the immediate postpartum period, however, aggressively progressing thrombocytopenia posed a diagnostic dilemma to the interdisciplinary care team. After failing to respond to first-line therapies including high-dose corticosteroids and intravenous immunoglobulin, she was successfully managed with a trial of the thrombopoietin receptor agonist, Romiplostim.